Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. - Wikidata - wikimedia - TriplyDB

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

http://www.wikidata.org/entity/Q35012945

about

The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88 BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway Severe infectious diseases of childhood as monogenic inborn errors of immunity Differential impact of Toll-like receptor signaling on distinct B cell subpopulations Deconstructing innate immune signaling in myelodysplastic syndromes Role of innate immunity in neonatal infection The TLR and IL-1 signalling network at a glance Primary immunodeficiency for the primary care provider Neutrophils: Between host defence, immune modulation, and tissue injury IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants Patterns of Allergic Sensitization in High IgE Syndromes.IRAK4 Deficiency in a Patient with Recurrent Pneumococcal Infections: Case Report and Review of the Literature.Clearance of Pneumocystis murina infection is not dependent on MyD88 B cell TLRs and induction of immunoglobulin class-switch DNA recombination.A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.Essential role of interleukin-1 signaling in host defenses against group B streptococcus.TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling.Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and Disease Control of Toll-like receptor-mediated T cell-independent type 1 antibody responses by the inducible nuclear protein IκB-ζ Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in mice IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4 Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response.Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.Invasive pneumococcal diseases in children and adolescents--a single centre experience Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics.Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.Uncoupling of pro- and anti-inflammatory properties of Staphylococcus aureus.NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus.Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling.Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity.Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study Innate immune responses to Pseudomonas aeruginosa infection.Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia.Toll-like receptor genetic variants are associated with Gram-negative infections in VLBW infants.

P2860

Q24299592-D66CC7F3-BA4B-41AD-8721-19A493BA441E Q24301912-73F2838D-B93A-4434-A0D7-BB3C325C1B24 Q24621930-EEB8F3B2-A3DA-473F-B1FD-125FAC276E47 Q24632504-29BA0070-4F25-4808-8052-51E3C67B7817 Q26775891-24E29957-5F40-4A83-BBB8-54348104DB81 Q26825241-38455A3A-0E66-4AF7-8EF6-0AE769D60ED3 Q26991974-5CC8E799-A331-4513-98DE-56335572D31C Q26999064-A0977D67-9E4C-4DF3-9941-613D31A53DC1 Q27013358-49CF86B5-DC05-491C-9E08-1BE2CCCEF222 Q28066058-5E3514F7-129E-4D2C-A5A5-BB2D085F10DD Q28087227-45CFE391-6E65-4706-A2F1-9997C6E3F3EE Q28710292-8DE20058-0D0F-4254-9FB7-9125431C6A51 Q28741059-DB10D5E1-2AD2-4CFC-A99C-25F66612A6A5 Q30278478-0A026EFB-FA73-49DD-ADAB-95C7AD69191E Q33611375-5E1C1CF8-46CE-4A4C-9F79-82B0455F168F Q33807392-E54E7F14-FE03-4620-9354-8B32C98DB7A8 Q33893517-8EB34E16-D2C2-47E3-B9CC-DB3F28664CB9 Q34044755-C57E141E-5F31-485E-8868-4AF53D3DEC57 Q34197495-4E37B10E-154A-46E3-ACEC-4B5013B535B4 Q34222038-910AB2D3-453F-4DD0-978C-5F2111297248 Q34345726-CE363E31-ECE6-4E9F-92BC-86D11F38F461 Q34419556-590A41A5-53D2-489D-A34F-13B4BF2AC244 Q34467437-B83DAD7E-52D1-4554-B3B5-FE2F91C14A54 Q34499405-C20CD9C3-AEB3-4C53-B6CA-1BF5DAC0A898 Q34636867-39ACF724-ECD4-417E-BDA5-32F029D2F0E4 Q34795980-B01F6111-14F7-4027-AA29-CBFDDAA65AF0 Q34976606-ED7DFE10-FCC9-45D4-AC50-1CAACA5F4535 Q35090141-5923B0D4-498B-4EB9-8762-595D28AE2178 Q35119564-27A8D827-0182-4542-AD6A-36B8C287AE3F Q35147583-F574CC40-4D28-41F2-A828-A85FD46C535C Q35183900-B14189A6-1803-40D0-9E75-A7C5579F739E Q35187585-73834242-383B-40BB-B8E1-71900C30E1CB Q35190204-A89E96B5-077B-4EB9-8AE4-8D5E15E55163 Q35190461-39DC5437-7436-4BAB-BAE3-5AC16AC9817C Q35196768-D18A6423-B3D3-4733-831F-29D2F2471853 Q35237500-EA9E9385-4962-416F-96DF-325503A6F74A Q35462598-9445E7B6-4D7A-4F52-855D-5185A399E9D6 Q35566398-A00B95F1-3D62-436B-9D29-711FB44DB195 Q35671268-2E2EC9D6-B079-4D53-AACE-53D970F06632 Q35736420-8861D618-49BB-4D84-AEAF-C2C8743430FE

P2860

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

http://www.wikidata.org/entity/Q35012945

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

@ast

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

@en

type

label

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

@ast

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

@en

prefLabel

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

@ast

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

@en

P1433

Q35012945-C74DC175-F19C-42EE-ADF3-2E251A0871EC

P1476

Q35012945-4643F743-01B0-4B06-98A5-306BCED34D98

P2093

Q35012945-00F1FBE9-D218-4C93-93CB-BA3B1F0CC611

Q35012945-0DC8529D-F2A8-4881-B448-46CE23CE33CA

Q35012945-153825AE-9A09-43F2-B27E-7D06F6232798

Q35012945-1FD77394-5E72-4A5D-B5A4-B1A41FA8BD84

Q35012945-2671E31B-C772-48D5-B3A1-42D508CF56BF

Q35012945-3A26D76F-5C27-461B-B7C0-C71E5EF71410

Q35012945-49755DB8-45F8-4CA3-9128-79C46DE948B6

Q35012945-541F7D39-0DA1-4144-BF15-22D4F4D9AC23

Q35012945-55745209-54CC-4AFD-B086-858C14745979

Q35012945-6155B65A-3D52-4F72-A646-764824A4CF68

P2860

Q35012945-04798D21-DC83-4218-8821-94E7B4A2CC45

Q35012945-07D1788F-23A8-4EF1-B17E-0A963C75F4E2

Q35012945-0912908C-3805-425F-BBB7-8B59BAE73488

Q35012945-0BAFA554-69CD-4136-A15A-16FD6EA7CEF3

Q35012945-0C448E04-B739-4384-BC94-69670ABEEC07

Q35012945-0F7EB40A-FA3C-425F-A609-5E10FA0960BD

Q35012945-13914A0D-E5BF-4BE5-BD4A-EF2FD55949C2

Q35012945-1DA0DCA0-11DF-4B4D-8117-C82776CB3EFC

Q35012945-1E12CAB6-F2C8-425D-BFDB-254AA39B04CA

Q35012945-1F2A1A48-F995-416D-850A-6EB5491C7542

P304

Q35012945-07E0D88A-F23D-4D0D-80F1-3F8DE8D0614D

P31

Q35012945-2F159129-A33D-4FBC-AE89-3DFC3021AAB6

P356

Q35012945-039855D5-D47D-4ACA-B514-AF620F32995C

P407

Q35012945-1E7AF519-101E-4D45-BE0C-48C9B1C14735

P433

Q35012945-E398CAAC-9AE1-4E80-AF4D-F869C76E1775

P478

Q35012945-3C421933-6D1C-4E68-9428-010057966B88

P50

Q35012945-14D60D7C-788E-4B13-8B9D-C155E4E816D0

Q35012945-2FDBA1A3-C1F8-4B0C-9280-82DBCFAC4B52

Q35012945-38BF7936-89D2-45D6-B46B-B47C06755807

Q35012945-4F764BB4-FBBE-46C1-87A8-79B594E2C462

Q35012945-708230BD-B9E9-42A9-8D75-65AEA903C1FF

Q35012945-AA01DEBD-6FCA-4899-B82E-937231FF66F1

Q35012945-AB348C79-4BFA-4A46-8E72-2F976B146902

Q35012945-B8BD9A78-DF6E-4F73-9367-561DD10D79DE

Q35012945-B9D325F2-4A2E-45F7-83B6-90E61D0EB6C8

Q35012945-C220F067-BB5D-42C1-A4A3-A20EA2E968CD

P577

Q35012945-BF477B76-49F7-4E0B-A802-08BF0F7D0DEE

P698

Q35012945-DA4252AA-61F5-4FCF-8F0E-549CCE96F6AE

P932

Q35012945-DFEC174B-D254-412F-92B6-80F3C24CA187

P356

MD.0B013E3181FD8EC3

P1433

P1476

Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.

@en

P2093

Abdulaziz Al-Ghonaium

http://www.w3.org/2001/XMLSchema#string

Andrew C Issekutz

http://www.w3.org/2001/XMLSchema#string

Artur Bonito Vitor

http://www.w3.org/2001/XMLSchema#string

Ben-Zion Garty

http://www.w3.org/2001/XMLSchema#string

C Buddy Creech

http://www.w3.org/2001/XMLSchema#string

Carlos Rodriguez-Gallego

http://www.w3.org/2001/XMLSchema#string

Chaim Roifman

http://www.w3.org/2001/XMLSchema#string

Cheng-Lung Ku

http://www.w3.org/2001/XMLSchema#string

Claire Bethune

http://www.w3.org/2001/XMLSchema#string

Claudia Fortuny

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 12 deficiency associated with recurrent infections

Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses

SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms

Impaired neutrophil migration and phagocytosis in IRAK-4 deficiency

Toll-like receptor signalling

Combined immunodeficiency associated with DOCK8 mutations

Pyogenic bacterial infections in humans with MyD88 deficiency

Pyogenic bacterial infections in humans with IRAK-4 deficiency

Approaching the asymptote: 20 years later

Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity

P304

403-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0B013E3181FD8EC3

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Laurent Casanova

Capucine Picard

Peter D Arkwright

Juan I Arostegui

Joseph B Domachowske

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21057262

http://www.w3.org/2001/XMLSchema#string

P932

3103888

http://www.w3.org/2001/XMLSchema#string